SIRT Multidisciplinary AppRoach with TheraSphereTM Therapy
The SMARTT Y90 Programme is a unique peer-to-peer educational experience that explores how personalised and versatile TheraSphere Y90 Therapy can achieve high tumour response and downstaging rates while preserving liver function in patients at various stages of unresectable HCC.
This educational experience has been developed in co-operation with multi-disciplinary specialists who will take an active role in the delivery of the curriculum.
Engage in a dynamic forum with renown hepatologists and other liver cancer specialists on the importance of multidisciplinary collaboration in HCC treatment strategies. Interested in future SMARTT Y90 programme opportunities?
The 2024 Programme will feature livestream activity and face-to-face local and regional summit meetings. Our SMARTT Y90 Ask-the- Expert service will continue, offering you and your centre’s MDT the chance for a customised virtual meeting with members of the expanding SMARTT Y90 Faculty.
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.